GENB analyst estimates

Generate Biomedicines (GENB) analyst ratings, the average price target and its range, and every firm's latest call.

• 2 firms rate GENB: 2 buy, 0 hold, 0 sell.
• The average price target is $26.00 from None analysts, from $22.00 to $30.00.

Updated 2026-11-13 04:50 UTC